Dear Members,
The Board of Directors is pleased to present the Thirty-first (31st)
Annual Report on the business and operations of Medinova Diagnostic Services Limited
(the Company? or MDSL?) your Company along with the audited
financial statements for the financial year ended March 31, 2024.
FINANCIAL HIGHLIGHTS:
The financial performance of your Company for the year ended March 31,
2024, is summarized below:
( in Lakhs)
|
Standalone |
Consolidated |
Particulars |
|
|
|
|
|
FY 2023-24 |
FY 2022-23 |
FY 2023-24 |
FY 2022-23 |
Total Income |
803.90 |
799.11 |
1036.34 |
1021.81 |
Total Expenses |
702.23 |
712.04 |
808.45 |
831.80 |
Profit before Tax |
101.67 |
87.07 |
227.89 |
190.01 |
Total Tax Expenses |
26.40 |
24.07 |
28.00 |
23.49 |
Profit after Tax |
75.27 |
63.00 |
199.89 |
166.52 |
EPS (in ) |
0.75 |
0.63 |
2.00 |
1.67 |
FINANCIAL PERFORMANCE REVIEW:
STANDALONE
During the year under review, the Company generated total income of
803.90 Lakhs as compared to
799.11 Lakhs in the previous year. The operations resulted in a net
profit after tax of 75.27 Lakhs as against net profit after tax of 63 Lakhs in the
previous year.
CONSOLIDATED
During the year under review, the Company generated total income of
1036.34 Lakhs as against 1021.81 Lakhs in the previous year. The operations resulted in a
net profit after tax of 199.89 Lakhs as against net profit after tax of 166.52
Lakhs in the previous year.
CONSOLIDATED FINANCIAL STATEMENTS:
The Standalone and Consolidated Financial Statements of the Company for
the financial year ended March 31, 2024, are prepared in accordance with the applicable
provisions of Companies Act 2013
("Act"), Indian Accounting Standards ("Ind-AS") and
SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 ("Listing
Regulations"). The consolidated financial statements have been prepared based on
audited financial statements of the Company and its subsidiaries as approved by their
respective Board of Directors.
DIVIDEND:
The Board has not recommended any dividend for the year financial year
2023-24.
TRANSFER TO GENERAL RESERVES:
During the year under review, the Company has not transferred any
amount to reserves.
SHARE CAPITAL:
During the financial year 2023-24, there was no change in the
authorised, subscribed, issued and paid-up share capital of the Company. As on March 31,
2024, the paid-up share capital of the Company stood at
9,98,16,400/- divided into 99,81,640 equity shares of 10/- each.
SUBSIDIARY COMPANIES:
Your Company does not have any Subsidiary Companies. However, as per
explanation given to Section 2(87) of Companies Act, 2013 which defines Subsidiary
Company, the Medinova Millennium MRI Services LLP is considered as a subsidiary being a
body corporate.
Pursuant to proviso to Section 129(3) of the Act, a statement
containing the brief details of performance and financials of the Subsidiary LLP for the
financial year ended March 31, 2024 is attached as Annexure-A and forms part of
this Report.
None of the Companies have become or ceased to be its Subsidiaries,
joint ventures or associate companies during the year under review.
The annual financial statements of the subsidiary company will be made
available to the members of the Company seeking such information and the same are
available at the website of the Company www.medinovaindia.com under Investors?
section.
DIRECTORS AND KEY MANAGERIAL PERSONNEL:
In accordance with the provisions of Section 152 and other applicable
provisions, if any, of the Companies Act, 2013 and the Articles of Association of the
Company, Mr. Sunil Chandra Kondapally (DIN:01409332), will retire by rotation at the
ensuing Annual General Meeting and being eligible offered himself for reappointment.
A brief profile of Mr. Sunil Chandra Kondapally and other related
information is detailed in the Notice convening the 31st AGM of your Company.
The Company has received declarations / confirmations from all the
Independent Directors of the Company confirming that they meet the criteria of
independence as prescribed under Companies Act and Listing Regulations. Further all the
Independent Directors have confirmed that their respective names have been included in the
Independent Director?s Database as required under Section 150 of the
Companies Act 2013.
In the opinion of the Board, Independent Directors fulfill the
conditions specified in the Companies Act and Listing Regulations and are independent from
management.
CHANGES IN COMPOSITION OF DIRECTORS AND KMP:
i. Mr. K V Ravindra Reddy, Independent Director of the Company
completed his tenure as
Independent Director and retired from the Board of the Company w.e.f.
March 31, 2024. ii. Mr. Ravi Kumar Reddy Kanamatareddy was appointed as an additional
director in the category of Non-executive Independent Director w.e.f. June 21, 2024. iii.
Mr. Madhava Reddy Beeravelli, resigned from the post of Chief Financial Officer w.e.f.
December 21, 2023. iv. Mr. Nikhil Rajmal Jain was appointed as the
Chief Financial Officer w.e.f. January 31, 2024.
Except as stated above, there were no changes in Directors and Key
Managerial Personnel of the Company during the year under review.
MEETINGS OF BOARD:
During the year under review, the Board of Directors met Four (4)
times. The composition of directors, their attendance and other details are as follows:
|
|
|
Name of the Directors |
|
Date of Board Meeting(s) |
Mr. K V Ravindra Reddy |
Dr. Sura Surendranath
Reddy |
Mrs. B. Vishnu Priya
Reddy |
Mr. K. Sunil Chandra |
Mr. P Kamalak ar Rao |
|
|
(Whether attended
"Yes/No" ) |
|
May 17, 2023 |
No |
Yes |
Yes |
Yes |
Yes |
July 28, 2023 |
Yes |
Yes |
Yes |
Yes |
No |
November 02, 2023 |
Yes |
Yes |
Yes |
Yes |
Yes |
January 31, 2024 |
Yes |
Yes |
Yes |
No |
Yes |
ANNUAL EVALUATION OF BOARD?S PERFORMANCE:
Pursuant to the provisions of the Companies Act and the Listing
Regulations, the Board has carried out the annual performance evaluation of the Directors
including Independent Directors, Board as a whole and Committees of the Board.
Questionnaire(s) for the purpose of evaluation have been framed on
various parameters for each of the categories. These include quantitative questions along
with an option to provide feedback for overall performance. Evaluation has been carried
out by way of assigning the relevant rating in the range of 1-5 in the questionnaire(s).
The evaluation criteria for the Directors other than Independent
Directors include adequate knowledge, competency, business & functional knowledge,
leadership abilities, Professional conduct integrity etc. Evaluation criteria for
Independent Directors include additional parameters such as independent judgement,
independence, conflict of interest etc. Evaluation criteria for Committees of the Board
include composition of committees, adequate representation of independent directors in the
committees, recommendations of the Committees to the Board, terms of references of the
Committees etc. Evaluation criteria for performance of the Board as a whole includes
Composition of Board, Board process, corporate governance, disclosures etc.
Further Independent directors had separately met to evaluate the
performance of Non Independent Directors, Board as a whole, Chairperson and to assess the
quality, quantity and timeliness of flow of information between the Company management and
the Board.
The Directors expressed their satisfaction with the evaluation process.
COMMITTEES OF THE BOARD AUDIT COMMITTEE:
The Company has in place an Audit Committee in terms of the
requirements of the Companies Act, 2013 read with the Rules made thereunder.
As on March 31, 2024, the composition of Audit Committee was as
follows:
1. |
Mr. P Kamalakar Rao |
Chairman |
2. |
Mr. KV Ravindra Reddy |
Member |
3. |
Dr. Sura Surendranath Reddy |
Member |
The Compliance Officer of the Company acts as the Secretary of the
Audit Committee.
The Audit Committee met 4 (four) times during the FY 2023-24 and the
details of attendance of the meetings are as given hereunder;
Date of Audit Committee Meeting(s) |
|
Name of the Members |
|
Mr. P Kamalakar Rao
(Chairman) |
Mr. KV Ravindra Reddy
(Member) |
Dr. Sura Surendranath
Reddy (Member) |
|
|
(Whether attended
"Yes/No") |
May 17, 2023 |
Yes |
No |
Yes |
July 28, 2023 |
No |
Yes |
Yes |
November 02, 2023 |
Yes |
Yes |
Yes |
January 31, 2024 |
Yes |
Yes |
Yes |
NOMINATION AND REMUNERATION COMMITTEE:
The Company has in place Nomination and Remuneration Committee in terms
of the requirements of the Companies Act, 2013 read with the Rules made thereunder.
As on March 31, 2024, the composition of Nomination and Remuneration
Committee was as follows:
1. |
Mr. KV Ravindra Reddy |
Chairman |
2. |
Mr. P Kamalakar Rao |
Member |
3. |
Dr. Sura Surendranath Reddy |
Member |
The Nomination and Remuneration Committee met 2 (two) times during the
FY 2023-24 and the details of attendance of the meetings are as given hereunder;
Date of Nomination Remuneration
Committee Meeting(s) |
|
Name of the Members |
|
|
Mr. KV Ravindra
Reddy (Chairman) |
Mr. P Kamalakar Rao
(Member) |
Dr. Sura Surendranath
Reddy (Member) |
|
|
(Whether attended
"Yes/No") |
May 17, 2023 |
No |
Yes |
Yes |
January 31, 2024 |
Yes |
Yes |
Yes |
STAKEHOLDERS RELATIONSHIP COMMITTEE:
The Company has in place a Stakeholders Relationship Committee in terms
of the requirements of the Companies Act, 2013 read with the Rules made thereunder.
As on March 31, 2024, the composition of Stakeholders Relationship
Committee was as follows:
1. |
Mr. KV Ravindra Reddy |
Chairman |
2. |
Mr. P Kamalakar Rao |
Member |
3. |
Dr. Sura Surendranath Reddy |
Member |
The Stakeholders Relationship Committee met 2 (two) times during the FY
2023-24 and the details of attendance of the meetings are as given hereunder;
Date of |
|
Name of the Members |
|
Stakeholders Relationship
Committee Meeting(s) |
Mr. KV Ravindra Reddy
(Chairman) |
Mr. P Kamalakar Rao
(Member) |
Dr. Sura Surendranath
Reddy (Member) |
|
|
(Whether attended
"Yes/No") |
|
May 17, 2023 |
No |
Yes |
Yes |
January 31, 2024 |
Yes |
No |
Yes |
VIGIL / WHISTLE BLOWER MECHANISM:
Pursuant to the provisions of Section 177(9) & (10) of the
Companies Act, a Whistle Blower Policy for directors, employees and other stakeholders to
report genuine concerns has been established. The same has been uploaded on the website of
the Company and the web-link is http://www.medinovaindia.com/investors.php
PUBLIC DEPOSITS:
During the year under review, the Company has neither accepted nor
renewed any deposit within the meaning of Section 73 and 74 of the Companies Act, 2013
read together with Companies (Acceptance of Deposits) Rules, 2014.
LOANS, GUARANTEES AND INVESTMENTS:
The details of loans, guarantees/securities and investments by the
Company, are provided in Notes to financial statements in terms of provisions of Companies
Act and Listing Regulations.
RELATED PARTY TRANSACTIONS:
All the related party transactions entered into during the financial
year were on arm?s length basis and in ordinary course of business. There are no
materially significant related party transactions made by the Company during the financial
year under review. Accordingly, disclosure of related party transactions as required under
Section 134(3)(h) of the Companies Act in prescribed format Form AOC-2 is not applicable.
The Board has approved a policy for related party transactions and the
said policy is available at website of the Company at
http://www.medinovaindia.com/investors.php
MANAGEMENT?S DISCUSSION AND ANALYSIS:
The Management Discussion and Analysis (MDA?) Report
detailing the overall industry structure, developments, performance and state of affairs
of the Company?s business, risks and concerns and other material developments during
the Financial Year is annexed herewith as Annexure-B and forms an integral part of
this Annual Report.
CORPORATE GOVERNANCE:
Pursuant to Regulation 15 of Listing Regulations, provisions relating
to reporting on Corporate Governance as part of Annual Report of the Company, are not
applicable to the Company.
COST RECORDS:
During the year under review, maintenance of cost records and
requirement of cost audit as prescribed under the provisions of Section 148(1) of the
Companies Act, 2013 is not applicable to the Company.
AUDITORS:
a) Statutory Auditors
M/s. M. Anandam & Co., Chartered Accountants, Secunderabad, (Firm
Registration No. 000125S), Chartered Accountants, were appointed as Statutory Auditors of
the Company at the 28th Annual General Meeting held on August 04, 2021 for a
period of 5 years commencing form the conclusion of 28th Annual General Meeting
till the conclusion of 33rd Annual General Meeting to be held in the year 2026.
The firm has consented and confirmed that the appointment is within the limit specified
under section 141(3)(g) of the Companies Act, 2013. The Statutory Auditors have also
confirmed that they are not disqualified to be appointed as such in terms of the proviso
to Section 139(1), 141(2) and 141(3) of the Companies Act, 2013 and the Companies (Audit
and Auditors) Rules, 2014.
The Audit Report of M/s. M. Anandam & Co., on the Financial
Statements of the Company for the Financial Year 2023-24 is part of this Annual Report and
the report does not contain any qualification, reservation, adverse remark or disclaimer.
Further the Auditor?s Report being self-explanatory does not call for any further
comments from the Board of Directors.
The Auditors have not reported any frauds to the Audit Committee as
prescribed under Sec. 143(12) of the Companies Act, 2013.
b) Secretarial Auditors
Pursuant to the provisions of Section 204 of the Companies Act, 2013
and the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the
Board of Directors appointed Mr. D. Balarama Krishna, Practicing Company Secretary,
Hyderabad as Secretarial auditor to undertake the Secretarial Audit of the Company for the
financial year 2023-24. The Secretarial Audit Report is available as Annexure-C to
this report.
There are no qualifications, reservation or adverse remark made in the
Secretarial Audit Report.
c) Internal Auditors
Mr. R. Jaipal Reddy was the Internal Auditor of the Company. However,
he has resigned w.e.f. June 1, 2024, and thereupon ceased be the Internal Auditor.
CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE
EARNINGS AND OUTGO:
The particulars as prescribed under sub-section (3)(m) of Section 134
of the Companies Act, 2013, read with the Companies (Accounts) Rules, 2014, are as
follows:
A. Conservation of Energy
The operations of your company do not consume high levels of energy. In
its endeavour towards conservation of energy your Company ensures optimal use of energy,
avoid wastages and endeavours to conserve energy as far as possible.
B. Technology Absorption
Your Company has not carried out any research and development
activities and haven?t absorbed any technology during the year under review.
C. Foreign Exchange Earnings and outgo: Nil
ANNUAL RETURN:
A copy of the Annual Return as required under Section 92(3) and Section
134(3)(a) of the Companies Act, 2013 has been placed on the Company?s website. The
web-link as required under the Act is http://www.medinovaindia.com/investors.php
RISK MANAGEMENT:
Your Company periodically assess the various elements and also
procedures to mitigate such risk, from time to time. As on date of this report, your
Company doesn?t foresee any critical risk, which threatens its existence. The details
of the risks concerning the Company are included in the Management Discussion and Analysis
Report.
INTERNAL FINANCIAL CONTROLS AND THEIR ADEQUACY:
Your Company has in place adequate internal financial controls
commensurate with the size, scale and complexity of its operations. The Company has
policies and procedures in place for ensuring proper and efficient conduct of its
business, the safeguarding of its assets, the prevention and detection of frauds the
accuracy and completeness of the accounting records and the timely preparation of reliable
financial information.
POLICY ON NOMINATION AND REMUNERATION:
In compliance with the requirements of Section 178 of the Act, the
Company has laid down a Nomination and Remuneration Policy which has been uploaded on the
Company?s website. The web-link as required under the Act is
http://www.medinovaindia.com/investors.php
The salient features of the NRC Policy are as under:
(1) Setting out the objectives of the Policy
(2) Appointment and removal of Directors, KMP and Senior Management
(3) Remuneration for the Executive Directors, KMP, Senior Management
Personnel & other employees (4) Remuneration to Non-Executive / Independent Directors
PARTICULARS OF EMPLOYEES:
Disclosures pertaining to remuneration and other details as required
under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014, is annexed herewith as Annexure-D.
There were no employees who had drawn remuneration in excess of the
limits prescribed under Rule 5(2) of the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014 for the financial year 2023-24.
CORPORATE SOCIAL RESPONSIBILITY:
The provisions of Section 135 of the Companies Act, 2013 relating to
corporate social responsibility are not applicable to the Company in the reporting
financial year.
SIGNIFICANT AND MATERIAL ORDERS:
There are no significant and material orders passed by the regulators
or courts or tribunals impacting the going concern status and Company?s operations in
the future.
NATURE OF BUSINESS AND MATERIAL CHANGES:
There is no change in the nature of business carried on by the Company
during the year under review.
There are no Material Changes and Commitments affecting the financial
position of the Company which occurred between the end of the financial year to which the
financial statements relate and the date of this Report.
DISCLOSURE AS PER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE
(PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:
Your Company has adopted a policy against sexual harassment in line
with the provisions of Sexual Harassment of Women at Workplace (Prevention, Prohibition
and Redressal) Act, 2013 and the rules framed thereunder. The Company has constituted
Internal Complaints Committee for Redressal of complaints on sexual harassment. During the
year, the Company had not received any complaint on sexual harassment and no complaint was
pending as on March 31, 2024.
DIRECTORS? RESPONSIBILITY STATEMENT:
Pursuant to the requirement under Section 134(5) of the Act, with
respect to Directors? Responsibility
Statement, your Directors, to the best of their knowledge and ability,
hereby confirm that:
a) in the preparation of the annual accounts, the applicable accounting
standards had been followed along with proper explanation relating to material departures;
b) we have selected such accounting policies and applied them
consistently and made judgements and estimates that are reasonable and prudent so as to
give a true and fair view of the state of affairs of the Company as at March 31, 2024 and
of the profit and loss of the Company for the year ended on that date;
c) we have taken proper and sufficient care for the maintenance of
adequate accounting records in accordance with the provisions of this Act for safeguarding
the assets of the Company and for preventing and detecting fraud and other irregularities;
d) the annual accounts have been prepared on a going concern basis;
e) the Company had laid down internal financial controls to be followed
by the Company and that such internal financial controls are adequate and were operating
effectively; and
f) we have devised proper systems to ensure compliance with the
provisions of all applicable laws and that such systems were adequate and operating
effectively.
DISCLSOURE RELATED TO INSOLVENCY AND BANKRUPTCY:
During the year under review, there is no application made and/or no
proceeding pending under the Insolvency and Bankruptcy Code, 2016.
DETAILS OF DIFFERENCE BETWEEN THE AMOUNT OF VALUATION AT THE TIME OF
ONE-TIME SETTLEMENT AND THE VALUATION DONE AT THE TIME OF TAKING A LOAN FROM THE BANKS OR
FINANCIAL INSTITUTIONS ALONG WITH THE REASONS THEREOF:
During the year under review, the Company has not made any settlement
with its bankers for any loan(s) / facility(ies) availed or / and still in existence.
ACKNOWLEDGMENT:
Your Directors place on record their sincere appreciation and thanks
for the valuable cooperation and support received from the employees of the Company at all
levels, Company?s Bankers, Associates, partners, clients, vendors, and Members
of the Company and look forward for the same in equal measure in the coming years.
By the Order of the Board For Medinova Diagnostic Services Limited
Date: June 21, 2024 |
Dr. Sura Surendranath Reddy |
Place: Hyderabad |
Chairman |
|
DIN: 00108599 |